✦ LIBER ✦

Utilization of intravenous tissue plasminogen activator for acute ischemic stroke

✍ Scribed by I.L Katzan; M.D Hammer; E.D Hixson

Book ID: 113414131
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 36 KB
Volume: 13
Category: Article
ISSN: 1062-1458
DOI: 10.1016/j.accreview.2004.04.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comment on: A Cost-Utility Analysis of M

Comment on: A Cost-Utility Analysis of Mechanical Thrombectomy as an Adjunct of Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke

✍ J. Kollmer; S. Rohde 📂 Article 📅 2011 🏛 Springer 🌐 German ⚖ 188 KB

Mechanical Disruption of Thrombus Follow

Mechanical Disruption of Thrombus Following Intravenous Tissue Plasminogen Activator for Ischemic Stroke

✍ Adnan I. Qureshi; Nazli Janjua; Jawad F. Kirmani; Pansy Harris-Lane; M. Fareed K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Intravenous tissue plasminogen activator

Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients

✍ Satoru Takeuchi; Kojiro Wada; Kimihiro Nagatani; Naoki Otani; Hideo Osada; Hiros 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 45 KB

Apolipoprotein E phenotype and the effic

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

✍ Joseph Broderick; Mei Lu; Christy Jackson; Arthur Pancioli; Barbara C. Tilley; S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

Early Computed Tomography Hypodensity Pr

Early Computed Tomography Hypodensity Predicts Hemorrhage After Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke

✍ Neeraj Dubey; Rohit Bakshi; Mohammed Wasay; Jacek Dmochowski 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Medico-Legal Aspects of Using Tissue Pla

Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke

✍ Nhu T. Bruce; William P. Neil; Justin A. Zivin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 109 KB

## Opinion statement Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a f